Drugs / Azka Nasal and Throat for Children
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06761339 | Dec 2024 → Feb 2025 | mucus inspissation of respiratory tract | Haiphong University of Medicine and Pharmacy | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Azka Nasal and Throat for Children | “Azka Nasal and Throat for Children is provided as a liquid oral preparation, designed with a pleasant flavor to ensure compliance in pediatric patients.” NCT06761339 ↗ |
| Route | Oral | “The intervention involves administering 7.5 ml per dose three times daily, taken orally 30 minutes before meals, for a duration of 7 days.” NCT06761339 ↗ |